{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:49:42Z","timestamp":1793663382369,"version":"4.5.1"},"reference-count":115,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100015615","name":"National Drug Abuse Treatment Clinical Trials Network","doi-asserted-by":"publisher","award":["UG1DA040316"],"award-info":[{"award-number":["UG1DA040316"]}],"id":[{"id":"10.13039\/100015615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:p>In the last decade, the U.S. opioid overdose crisis has magnified, particularly since the introduction of synthetic opioids, including fentanyl. Despite the benefits of medications for opioid use disorder (MOUD), only about a fifth of people with opioid use disorder (OUD) in the U.S. receive MOUD. The ubiquity of pharmacists, along with their extensive education and training, represents great potential for expansion of MOUD services, particularly in community pharmacies. The National Institute on Drug Abuse\u2019s National Drug Abuse Treatment Clinical Trials Network (NIDA CTN) convened a working group to develop a research agenda to expand OUD treatment in the community pharmacy sector to support improved access to MOUD and patient outcomes. Identified settings for research include independent and chain pharmacies and co-located pharmacies within primary care settings. Specific topics for research included adaptation of pharmacy infrastructure for clinical service provision, strategies for interprofessional collaboration including health service models, drug policy and regulation, pharmacist education about OUD and OUD treatment, including didactic, experiential, and interprofessional curricula, and educational interventions to reduce stigma towards this patient population. Together, expanding these research areas can bring effective MOUD to where it is most needed.<\/jats:p>","DOI":"10.1177\/08897077231203849","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T05:49:47Z","timestamp":1698644987000},"page":"264-276","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":13,"title":["Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy"],"prefix":"10.1177","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0583-308X","authenticated-orcid":false,"given":"Jennie B.","family":"Jarrett","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, University of Illinois Chicago, Chicago, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2240-5768","authenticated-orcid":false,"given":"Jeffrey","family":"Bratberg","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Clinical Research, College of Pharmacy, University of Rhode Island, Kingston, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Burns","sequence":"additional","affiliation":[{"name":"American Pharmacists Association, Washington, DC, USA (retired)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0153-0252","authenticated-orcid":false,"given":"Gerald","family":"Cochran","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, School of Medicine, University of Utah, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany A.","family":"DiPaula","sequence":"additional","affiliation":[{"name":"Department of Practice, Sciences, and Health Outcomes Research, School of Pharmacy, University of Maryland Baltimore, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Legreid Dopp","sequence":"additional","affiliation":[{"name":"American Society of Health-System Pharmacists, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Elmes","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, University of Illinois Chicago, Chicago, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci C.","family":"Green","sequence":"additional","affiliation":[{"name":"COBER on Opioids and Overdose at Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA"},{"name":"Opioid Policy Research Collaborative, The Heller School for Social Policy and Management, Brandeis University, Waltham, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-0159","authenticated-orcid":false,"given":"Lucas G.","family":"Hill","sequence":"additional","affiliation":[{"name":"The University of Texas at Austin, College of Pharmacy, Austin, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicity","family":"Homsted","sequence":"additional","affiliation":[{"name":"FQHC 340B Compliance, Inc., Lebanon, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Hsia","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, San Francisco School of Pharmacy, University of California, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele L.","family":"Matthews","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udi E.","family":"Ghitza","sequence":"additional","affiliation":[{"name":"National Institute on Drug Abuse (NIDA), Center for the Clinical Trials Network (CCTN), Bethesda, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Tzy","family":"Wu","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Bart","sequence":"additional","affiliation":[{"name":"Department of Medicine, Hennepin Healthcare, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"key":"bibr1-08897077231203849","volume-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2021 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration","year":"2022"},{"key":"bibr2-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103786"},{"key":"bibr3-08897077231203849","unstructured":"Ahmad F, Cisewski J, Rossen L, Sutton P. Provisional drug overdose death counts. Published January 5, 2023. Accessed February 9, 2023. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"bibr4-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.01.010"},{"key":"bibr5-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.05.050"},{"key":"bibr6-08897077231203849","doi-asserted-by":"publisher","DOI":"10.17226\/25310"},{"key":"bibr7-08897077231203849","doi-asserted-by":"publisher","DOI":"10.17226\/24781"},{"key":"bibr8-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-011-1962-8"},{"key":"bibr9-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1111\/add.13073"},{"key":"bibr10-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2021.106359"},{"key":"bibr11-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000633"},{"key":"bibr12-08897077231203849","author":"Substance Abuse and Mental Health Services Administration","year":"2021","journal-title":"Medications for Opioid Use Disorder"},{"key":"bibr13-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.07.013"},{"key":"bibr14-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201300235"},{"key":"bibr15-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201300256"},{"key":"bibr16-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2015.05.001"},{"key":"bibr17-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1111\/add.13193"},{"key":"bibr18-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"bibr19-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622"},{"key":"bibr20-08897077231203849","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3107"},{"key":"bibr21-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.01.010"},{"key":"bibr22-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.10.015"},{"key":"bibr23-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000408"},{"key":"bibr24-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.27488"},{"key":"bibr25-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1530\/ey.19.13.1"},{"key":"bibr26-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002207.pub2"},{"key":"bibr27-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1111\/add.13238"},{"key":"bibr28-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.1511"},{"key":"bibr29-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109294"},{"key":"bibr30-08897077231203849","unstructured":"How can patients access methadone in other countries? Accessed May 18, 2023. https:\/\/www.pewtrusts.org\/en\/research-and-analysis\/articles\/2023\/05\/17\/how-can-patients-access-methadone-in-other-countries"},{"key":"bibr31-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12686"},{"key":"bibr32-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108727"},{"key":"bibr33-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.03.014"},{"key":"bibr34-08897077231203849","unstructured":"Substance Abuse and Mental Health Services Administration. FAQs About the New Buprenorphine Practice Guidelines. Published March 3, 2022. Accessed May 23, 2022. https:\/\/www.samhsa.gov\/medication-assisted-treatment\/become-buprenorphine-waivered-practitioner\/new-practice-guidelines-faqs"},{"key":"bibr35-08897077231203849","unstructured":"Doyle S, Baaklini V. President signs bipartisan measure to improve addiction treatment. Pew. Published December 30, 2022. Accessed February 9, 2023. https:\/\/www.pewtrusts.org\/en\/research-and-analysis\/articles\/2022\/12\/30\/president-signs-bipartisan-measure-to-improve-addiction-treatment"},{"key":"bibr36-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-019-00143-6"},{"key":"bibr37-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.51856"},{"key":"bibr38-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.07.005"},{"key":"bibr39-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102722"},{"key":"bibr40-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1942395"},{"key":"bibr41-08897077231203849","doi-asserted-by":"publisher","DOI":"10.2174\/1874473711104010028"},{"key":"bibr42-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32812-X"},{"key":"bibr43-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000931"},{"key":"bibr44-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.02.031"},{"key":"bibr45-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107968"},{"key":"bibr46-08897077231203849","doi-asserted-by":"publisher","DOI":"10.7326\/M18-3457"},{"key":"bibr47-08897077231203849","unstructured":"Baumgartner J, Gumas E, Gunja M. Too many lives lost: comparing overdose mortality rates and policy solutions across high-income countries. improving health care quality. Published May 19, 2022. https:\/\/www.commonwealthfund.org\/blog\/2022\/too-many-lives-lost-comparing-overdose-mortality-rates-policy-solutions"},{"key":"bibr48-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2022.07.003"},{"key":"bibr49-08897077231203849","doi-asserted-by":"publisher","DOI":"10.31478\/202004b"},{"key":"bibr50-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1111\/jrh.12307"},{"key":"bibr51-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2014.1205"},{"key":"bibr52-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2013.0541"},{"key":"bibr53-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.3505"},{"key":"bibr54-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1111\/add.15641"},{"key":"bibr55-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109518"},{"key":"bibr56-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108729"},{"key":"bibr57-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102701"},{"key":"bibr58-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2022.08.017"},{"key":"bibr59-08897077231203849","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy7020059"},{"key":"bibr60-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.1900988"},{"key":"bibr61-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.06.008"},{"key":"bibr62-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.01.001"},{"key":"bibr63-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1186\/s40780-016-0066-3"},{"key":"bibr64-08897077231203849","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy9010057"},{"key":"bibr65-08897077231203849","unstructured":"National Alliance of State Pharmacy Associations. Pharmacist prescribing: statewide protocols and more. Resources. Published November 9, 2018. https:\/\/naspa.us\/resource\/swp\/"},{"key":"bibr66-08897077231203849","unstructured":"Tran T, Hill LG, Alliu V, Pham K. Issue Brief: Coordinated and Comprehensive Medication Management in Substance Use Disorder Treatment and Recovery. Alliance for Addiction Payment Reform; 2022. https:\/\/bit.ly\/3LiIB0Q"},{"key":"bibr67-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxab003"},{"key":"bibr68-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1002\/jac5.1331"},{"key":"bibr69-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1002\/jac5.1405"},{"key":"bibr70-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000520"},{"key":"bibr71-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxaa405"},{"key":"bibr72-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1002\/jac5.1607"},{"key":"bibr73-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2015.14177"},{"key":"bibr74-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1111\/add.15353"},{"key":"bibr75-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2208055"},{"key":"bibr76-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2021.10.007"},{"key":"bibr77-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2020.10.004"},{"key":"bibr78-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2022.01.016"},{"key":"bibr79-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2018.12.016"},{"key":"bibr80-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.09.009"},{"key":"bibr81-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1186\/s12961-021-00789-9"},{"key":"bibr82-08897077231203849","unstructured":"National Association of Chain Drug Stores. Improve Patients\u2019 Access to Pharmacist Services Co-Sponsor H.R. 592\/S. 314 the Pharmacy and Medically Underserved Areas Enhancement Act. National Association of Chain Drug Stores; 2015. Accessed December 28, 2022. http:\/\/www.nacds.org\/pdfs\/government\/ProviderStatus_Issue_Brief.pdf"},{"key":"bibr83-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2007.06124"},{"key":"bibr84-08897077231203849","unstructured":"Agency for Healthcare Research and Quality. The Pharmacist\u2019s Role in Medication Safety. Published online September 2019. Accessed November 15, 2022. https:\/\/psnet.ahrq.gov\/primer\/pharmacists-role-medication-safety"},{"key":"bibr85-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2020.1787300"},{"key":"bibr86-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxaa389"},{"key":"bibr87-08897077231203849","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy9040183"},{"key":"bibr88-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1177\/0897190018791060"},{"key":"bibr89-08897077231203849","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy8030137"},{"key":"bibr90-08897077231203849","unstructured":"MDL 2804 Opiate Litigation. Accessed December 28, 2022. https:\/\/www.ohnd.uscourts.gov\/mdl-2804"},{"key":"bibr91-08897077231203849","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy8030128"},{"key":"bibr92-08897077231203849","unstructured":"Bannow T. CVS to aggressively expand healthcare services in stores. Mod Healthc. Published online June 2019. Accessed December 28, 2022. https:\/\/www.modernhealthcare.com\/patient-care\/cvs-opening-1500-new-retail-clinics-its-stores"},{"key":"bibr93-08897077231203849","unstructured":"VillageMD. Our markets. Accessed March 1, 2022. https:\/\/www.villagemd.com\/"},{"key":"bibr94-08897077231203849","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2014.20.4.339"},{"key":"bibr95-08897077231203849","unstructured":"Centers for Disease Control and Prevention. Collaborative Practice Agreements and Pharmacists\u2019 Patient Care Services. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2013. https:\/\/www.cdc.gov\/dhdsp\/pubs\/docs\/translational_tools_pharmacists.pdf"},{"key":"bibr96-08897077231203849","volume-title":"Advancing Team-Based Care Through Collaborative Practice Agreements: A Resource and Implementation Guide for Adding Pharmacists to the Care Team","author":"Centers for Disease Control and Prevention","year":"2017"},{"key":"bibr97-08897077231203849","unstructured":"Pharmacy Times. Could Prescribing Become a Daily Duty for Pharmacists? Published May 2016. Accessed November 15, 2022. https:\/\/www.pharmacytimes.com\/view\/could-prescribing-become-a-daily-duty-for-pharmacists"},{"key":"bibr98-08897077231203849","unstructured":"Robeznieks A. AMA opposes HHS move to expand pharmacists\u2019 scope of practice. American Medical Association. Published August 2020. Accessed December 28, 2022. https:\/\/www.ama-assn.org\/practice-management\/scope-practice\/ama-opposes-hhs-move-expand-pharmacists-scope-practice"},{"key":"bibr99-08897077231203849","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2018.01.014"},{"key":"bibr100-08897077231203849","doi-asserted-by":"publisher","DOI":"10.5688\/ajpe8421"},{"key":"bibr101-08897077231203849","doi-asserted-by":"publisher","DOI":"10.31478\/202206a"},{"key":"bibr102-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2019.1694618"},{"key":"bibr103-08897077231203849","unstructured":"Opioid-Related Activities | AACP. Accessed January 11, 2023. https:\/\/www.aacp.org\/opioid"},{"key":"bibr104-08897077231203849","doi-asserted-by":"publisher","DOI":"10.5688\/ajpe8926"},{"key":"bibr105-08897077231203849","doi-asserted-by":"publisher","DOI":"10.5688\/ajpe8354"},{"key":"bibr106-08897077231203849","unstructured":"pgy2-newly-approved-psychiatric-pharmacy-2016.pdf. Accessed January 11, 2023. https:\/\/www.ashp.org\/-\/media\/assets\/professional-development\/residencies\/docs\/pgy2-newly-approved-psychiatric-pharmacy-2016.ashx"},{"key":"bibr107-08897077231203849","unstructured":"pgy2-pain-management-palliative-care.pdf. Accessed January 11, 2023. https:\/\/www.ashp.org\/-\/media\/assets\/professional-development\/residencies\/docs\/pgy2-pain-management-palliative-care.ashx"},{"key":"bibr108-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2022.12.001"},{"key":"bibr109-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2022.10.031"},{"key":"bibr110-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2021.2010162"},{"key":"bibr111-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1097\/CEH.0000000000000233"},{"key":"bibr112-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1097\/CEH.0000000000000317"},{"key":"bibr113-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2022.100204"},{"key":"bibr114-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000003053"},{"key":"bibr115-08897077231203849","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2016.12.069"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08897077231203849","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08897077231203849","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08897077231203849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:40:27Z","timestamp":1777668027000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08897077231203849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":115,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1177\/08897077231203849"],"URL":"https:\/\/doi.org\/10.1177\/08897077231203849","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}